Author: Dr. David Lowemann

FDA: Lilly Weight-Loss Drug Shortage Resolved

The U.S. Food and Drug Administration said on Thursday that Eli Lilly’s weight-loss drug shortage has been resolved, following a re-evaluation of the drug’s supply by the agency. Still, the FDA said it would not take any action against compounding pharmacies making cheaper… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., […]

Published on December 19, 2024

Paranoia may be, in part, a visual problem

Could complex beliefs like paranoia have roots in something as basic as vision? A new study finds evidence that they might. When completing a visual perception task, in which participants had to identify whether one moving dot was chasing another moving dot, those with greater tendencies toward paranoid thinking (believing others intend them harm) and […]

Published on December 19, 2024

More calories — more consumption: Individuals with and without obesity both prefer high-calories food, study finds

Higher calorie foods were preferred among individuals with and without obesity despite similar taste and texture, according to a new study. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for […]

Published on December 19, 2024